IN2014MU00455A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00455A
IN2014MU00455A IN455MU2014A IN2014MU00455A IN 2014MU00455 A IN2014MU00455 A IN 2014MU00455A IN 455MU2014 A IN455MU2014 A IN 455MU2014A IN 2014MU00455 A IN2014MU00455 A IN 2014MU00455A
Authority
IN
India
Prior art keywords
disclosure
novel crystalline
dolutegravir sodium
crystalline dolutegravir
sodium
Prior art date
Application number
Inventor
Ramakoteswara Rao Jetti
Satish Beeravelly
Madhu Murthy Nadella
Haribabu Nandipati
Original Assignee
Mylan Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Lab Ltd filed Critical Mylan Lab Ltd
Priority to IN455MU2014 priority Critical patent/IN2014MU00455A/en
Publication of IN2014MU00455A publication Critical patent/IN2014MU00455A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

The present disclosure relates to novel crystalline dolutegravir sodium Form-M2, Form-M3, Form-M4 and process for the preparation thereof.
IN455MU2014 2014-02-07 2015-02-04 IN2014MU00455A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN455MU2014 IN2014MU00455A (en) 2014-02-07 2015-02-04

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/IB2015/050841 WO2015118460A1 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
IN455MU2014 IN2014MU00455A (en) 2014-02-07 2015-02-04
EP15710893.7A EP3102582A1 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
US15/114,991 US10087193B2 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
CA2938103A CA2938103A1 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
AU2015215630A AU2015215630B2 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium

Publications (1)

Publication Number Publication Date
IN2014MU00455A true IN2014MU00455A (en) 2015-09-25

Family

ID=53777379

Family Applications (1)

Application Number Title Priority Date Filing Date
IN455MU2014 IN2014MU00455A (en) 2014-02-07 2015-02-04

Country Status (6)

Country Link
US (1) US10087193B2 (en)
EP (1) EP3102582A1 (en)
AU (1) AU2015215630B2 (en)
CA (1) CA2938103A1 (en)
IN (1) IN2014MU00455A (en)
WO (1) WO2015118460A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2956662A1 (en) * 2014-07-29 2016-02-04 Lek Pharmaceuticals D.D. Novel hydrates of dolutegravir sodium
EP3337479A4 (en) 2015-08-19 2019-04-03 Laurus Labs Limited Novel polymorphs of dolutegravir and salts thereof
WO2017046131A1 (en) * 2015-09-15 2017-03-23 Ratiopharm Gmbh Processes for preparing solid state forms of dolutegravir sodium
WO2017208105A1 (en) 2016-05-30 2017-12-07 Lupin Limited Novel crystalline form of dolutegravir sodium
WO2019048808A1 (en) 2017-09-07 2019-03-14 Cipla Limited New polymorphs of dolutegravir sodium
WO2020161742A1 (en) * 2019-02-05 2020-08-13 Msn Laboratories Private Limited, R&D Center Novel crystalline polymorphs of sodium (4r,12as)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido [1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009325128B2 (en) 2008-12-11 2015-01-29 Shionogi & Co., Ltd. Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
WO2013038407A1 (en) 2011-09-14 2013-03-21 Mapi Pharma Ltd. Amorphous form of dolutegravir
WO2015009927A1 (en) 2013-07-17 2015-01-22 Ratiopharm Gmbh Dolutegravir salts
WO2015019310A1 (en) * 2013-08-07 2015-02-12 Mylan Laboratories Ltd Process for the preparation of dolute-gravir and intermediates thereof

Also Published As

Publication number Publication date
US10087193B2 (en) 2018-10-02
WO2015118460A1 (en) 2015-08-13
AU2015215630A1 (en) 2016-09-22
US20160347766A1 (en) 2016-12-01
EP3102582A1 (en) 2016-12-14
AU2015215630B2 (en) 2018-08-16
CA2938103A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
EP3273992A4 (en) Antibodies to icos
EP3151672A4 (en) Improved t cell compositions
EP3143784A4 (en) Real-time, crowd-sourced, deo-location based system for enhancing personal safety
PH12016501700A1 (en) Combination therapies with anti-cd38 antibodies
EP3121175A4 (en) 1,3-benzodioxole derivative
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
PH12016501763A1 (en) Multispecific antibodies
IL252053D0 (en) תרכובות מותמרות של פירזולו(1, 5-a)פירימידינים ושימוש שלהן בטיפול בהפרעות רפואיות
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3109301A4 (en) Composition for heat cycle system, and heat cycle system
BR112014030067A2 (en) process for the manufacture of steam composition, and steam composition.
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
EP3109303A4 (en) Composition for heat cycle system, and heat cycle system
EP3109302A4 (en) Composition for heat cycle system, and heat cycle system
AU2015369965B2 (en) Enzymatically produced cellulose
EP3186277A4 (en) Antibodies, compositions, and uses
EP3109304A4 (en) Composition for heat cycle system, and heat cycle system
IN2014CH00247A (en)
EP3227174A4 (en) Segmented-foil divertor
PL2994229T3 (en) Process for the production of 1,3-butadiene
EP3341375A4 (en) Process for preparing parp inhibitor, crystalline forms, and uses thereof
EP3109298A4 (en) Composition for heat cycle system, and heat cycle system
BR112018001310A2 (en) bee-ingestible compositions, methods of use thereof for the production of honey and honey produced by these
EP3169389A4 (en) Headgear clip arrangement